Royal London Asset Management
INSM icon

Royal London Asset Management’s Insmed INSM Stock Holding History

Royal London Asset Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.36M Buy
22,116
+7,618
+53% +$922K ﹤0.01% 573
2026
Q1 		$2.37M Buy
14,498
+5,988
+70% +$921K 0.01% 573
2025
Q4 		$1.48M Buy
+8,510
New +$1.55M ﹤0.01% 589

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Royal London Asset Management's INSM Position: Q2 2026 in Review

Royal London Asset Management increased its Insmed (INSM) stake by 53% in Q2 2026, buying an estimated $922K and bringing the position to 22,116 shares worth $2.36M. The position accounts for ﹤0.01% of the portfolio, ranked #573.

Royal London Asset Management first reported a position in INSM in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.37M in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Royal London Asset Management held 22,116 shares of Insmed worth $2.36M as of Q2 2026.
  • Royal London Asset Management bought 7,618 Insmed shares in Q2 2026, an estimated $922K.
  • Insmed made up ﹤0.01% of Royal London Asset Management's portfolio in Q2 2026, its #573 holding.
  • Royal London Asset Management first reported a position in Insmed in Q4 2025 and has held it in 3 quarters since.
  • Royal London Asset Management's Insmed position peaked at $2.37M in Q1 2026.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Royal London Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.